Literature DB >> 31930099

Mesh-preservation approach to treatment of mesh infection after large incisional ventral hernia repair-how I do it.

Xuefei Yang1, Maimaiti Aihemaiti1, Hao Zhang1, Li Jiang1, Guixi Zhang1, Mali Qin1, Yiheng Pan1, Xiumei Wen1, Fion Siu Yin Chan1,2, Joe King Man Fan1,2.   

Abstract

Mesh infection after large incisional ventral hernia repair is a clinical dilemma in abdominal wall hernia surgery. It is believed foreign material should be removed but it causes secondary trauma to the abdominal wall tissue and might be associated with a higher risk of complications. Currently, there is no consensus on mesh-preservation treatment in cases of mesh infection after hernia repair in general. Herein we present the case of a 27-year-old male who recovered well from mesh infection after large incisional ventral hernia repair by mesh-preservation approach. The path to success is choice of material of prosthetic mesh; surgical approach of hernia repair, sufficient wound irrigation and drainage, and acquiring sterility of the mesh surface by wound care techniques such as local iodophor packing and vacuum sealing drainage. Clinical cohorts are needed to verify the feasibility of mesh-preservation treatment of mesh infection after large incisional hernia repair. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Large incisional hernia; mesh infection; mesh-preservation

Year:  2019        PMID: 31930099      PMCID: PMC6944596          DOI: 10.21037/atm.2019.10.82

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  2 in total

1.  Application of double circular suturing technique (DCST) in repair of giant incision hernias.

Authors:  Ying-Han Song; Wei-Jia Huang; Yan-Yan Xie; Gonish Hada; Sen Zhang; An-Qing Lu; Yong Wang; Wen-Zhang Lei
Journal:  Ann Transl Med       Date:  2020-06

Review 2.  Antimicrobial Meshes for Hernia Repair: Current Progress and Perspectives.

Authors:  Simona Mirel; Alexandra Pusta; Mihaela Moldovan; Septimiu Moldovan
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.